Vigabatrin is an antiepileptic drug that is used to treat seizures, particularly those associated with epilepsy. However, like all drugs, Vigabatrin may contain impurities, which are unwanted substances that can affect the quality, safety, and efficacy of the drug. The presence of impurities in Vigabatrin can lead to adverse effects on patients and can also affect the accuracy of analytical results. Therefore, it is important to control and monitor the levels of impurities in Vigabatrin and ensure that they are within acceptable limits.
